Document:

Exhibit
10.15

 

Amended
and restated

 

EMPLOYMENT AGREEMENT

 

BETWEEN

 

CLEMENTIA PHARMACEUTICALS USA INC.

 

AND

 

MR. JEFF PACKMAN

 

MADE AS
OF         , 2017

 

1

    	 

    	

    

EMPLOYMENT AGREEMENT

 

THIS AGREEMENT made as of                 , 2017,

 

B E T W E E N:

 

CLEMENTIA PHARMACEUTICALS USA INC., a corporation incorporated
under the laws of the state of Delaware, herein represented by Dr. Donna Grogan, President, duly authorized for the purposes hereof
as she so declares (the “Corporation”),

 

A N D:

 

MR. JEFF PACKMAN, domiciled and residing at                                         

(the “Employee”),

 

WHEREAS the Employee had been employed
by Clementia Pharmaceuticals Inc. (“Parent”), of which the Corporation is a wholly-owned subsidiary, since November
11, 2013 pursuant to an offer letter dated October 24, 2013 (the “Offer of Employment”);

 

WHEREAS, pursuant to an Agreement
and Assignment dated July 1, 2014, the Parent assigned all of its rights and obligations under the Offer of Employment to the Corporation
and the Corporation agreed to be bound by such rights and obligations, effective June 6, 2014;

 

WHEREAS, the Corporation and the Employee
are parties or an Employment Agreement made as of October 9, 2014 (the “Employment Agreement”);

 

WHEREAS, the Corporation wishes to
continue to employ the Employee and the Employee wishes to provide services to the Corporation on the terms and conditions set
forth in this Agreement;

 

WHEREAS, for the purposes of this
Agreement, any reference to employment or a period of employment with the Corporation shall be deemed to include the Employee’s
employment with the Parent; and

 

NOW, THEREFORE, in consideration of
the mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereto agree as follows:

 

ARTICLE
1 - INTERPRETATION

 

		1.01	Definition of Certain Terms

 

In this Agreement, unless something in the
subject matter or context is inconsistent therewith:

 

“280G Excise Tax” has the
meaning attributed thereto in Section 8.09(1) of this Agreement.

    	 

    	

    

“299% Amount” has the meaning
attributed thereto in Section 8.09(2) of this Agreement.

 

“Affiliate” of any Person
shall mean any other Person directly or indirectly controlling, controlled by, or under common control with, such Person; provided,
that, for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlled
by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the
ownership of voting securities, by contract or otherwise.

 

“Agreement” means this
agreement, including its recitals and schedules, as amended from time to time.

 

“Base Salary” has the meaning
attributed thereto in Section 3.01 of this Agreement.

 

“Benefit Plans” has the
meaning attributed thereto in Section 3.04 of this Agreement.

 

“Board” means the board
of directors of the Corporation in office from time to time.

 

“Business Day” means any
day other than a Saturday, Sunday or statutory or civic holiday in the State of Massachusetts.

 

“Cause” means: (i) any
theft, fraud, dishonesty, or serious misconduct by the Employee involving the property, business or affairs of the Corporation
or its Affiliates or the carrying out of the Employee’s duties, (ii) any material breach or non-observance by the Employee
of any term of this Agreement, including consistent failure or refusal to perform her duties or responsibilities, which breach
or non-observance is not cured, to the extent susceptible to cure, within fourteen (14) days after having been notified of such
by the Corporation, (iii) any conviction of, or plea of guilty or nolo contendere (or a similar plea) to a crime (other
than a misdemeanor traffic related offense),(iv) breach of fiduciary duty, conflict of interest or self-dealing, gross negligence,
willful misconduct or willful insubordination; or (v) violation of policies or procedures of the Company or its Affiliates, as
applicable, which is detrimental to the business, reputation, character or standing of the Corporation or any of its Affiliates.

 

“CEO” means Chief Executive
Officer.

 

“Change in Control” has
the meaning set forth in the Corporation’s 2017 Omnibus Incentive Plan.

 

“Code” has the meaning
attributable thereto in Section 8.08 of this Agreement.

 

“Conditional Capped Amount”
has the meaning attributable thereto in Section 8.09(1) of the Agreement.

 

“Confidential Information”
means confidential information of the Corporation, or any Affiliate or Subsidiary thereof, including trade secrets, customer lists,
Inventions, research results, research developments, data and materials supporting research results and research developments and
other confidential information concerning the business and affairs of the Corporation or any

    	2

    	

    

Affiliate or Subsidiary thereof. Confidential
Information does not include: (i) information that at the time of disclosure to the Employee is in the public domain or that, after
disclosure to Employee, became part of the public domain through no action or fault of employee, (ii) information that the Employee
can show to be known to Employee at the time of disclosure and not acquired directly or indirectly as a consequence of through
Employee’s service to the Company or any Affiliate or Subsidiary, or (iii) information that was received by Employee after
the Date of Termination from a third party having the legal right to transmit it.\

 

“Customer” means any Person
having purchased goods or services from the Corporation in connection with the Corporation’s business, namely the development
of RARgamma agonists or drugs for Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma (MO), at any time during
the two years preceding the termination of the Employee’s employment with the Corporation or with whom the Corporation is
in negotiation at the time the Employee’s employment ends with a view to selling or providing goods or services, in connection
with the Corporation’s business, to such Person.

 

“Date of Termination” means:

		(a)	if the Employee’s employment with the Corporation is terminated by the Employee in accordance with Section 7.02, or due
to the death, incapacity or retirement of the Employee, or for any other reason not otherwise contemplated by Article 7, the last
day of the Employee’s active employment with the Corporation; or

 

		(b)	if the Employee’s employment with the Corporation is terminated by the Corporation in accordance with Section 7.01, for
any reason whatsoever, with or without Cause, the date on which a proper Notice of Termination is delivered to the Employee or
such other termination date as specified in the Notice of Termination.

 

“Employment Agreement”
has the meaning attributed thereto in the recitals.

 

“Intellectual Property Rights”
means all trade secrets, copyrights, trade-marks, domain names, industrial designs, mask work rights, rights in integrated circuit
topographies, patents and other intellectual property rights recognized by the laws of any jurisdiction or country, including applications,
registrations, titles, renewals, issues, re-issues and extensions of the rights thereto.

 

“Invention” means any ideas,
concepts, devices, algorithms, information, materials, methods, processes, data, computer programs, databases, know-how, discoveries,
developments, designs, images, artwork, formulae, other copyrightable works, and techniques, including any enhancements, modifications
or additions thereto and/or to the products owned, licensed, sold, marketed or used by the Corporation, whether patentable or not,
and all Intellectual Property Rights therein.

 

“Parachute Payment” has
the meaning attributed thereto in Section 8.09(1) of this Agreement.

 

“Parent” has the meaning
attributed thereto in the recitals.

    	3

    	

    

“Person” is to be broadly
interpreted and includes an individual, a partnership, a corporation, a trust, a joint venture, any governmental authority or any
incorporated or unincorporated entity or association of any nature and the executors, administrators, or other legal representatives
of an individual in such capacity.

 

“Severance Period” means
the period beginning on the Date of Termination and ending after a period equal to nine (9) months following the Date of Termination.

 

“Subsidiary” with respect
to any Person, shall mean (a) any corporation more than fifty percent (50%) of the stock of any class or classes of which having
by the terms thereof ordinary voting power to elect a majority of the directors of such corporation (irrespective of whether or
not at the time stock of any class or classes of such corporation shall have or might have voting power by reason of the happening
of any contingency) is owned by such Person directly or indirectly through one or more subsidiaries of such Person and (b) any
partnership, association, joint venture, limited liability company or other entity in which such Person directly or indirectly
through one or more subsidiaries of such Person has more than a fifty percent (50%) equity interest.

 

“Territory” means the United
States and Canada.

 

		1.02	Headings

 

The division of this Agreement into Articles
and Sections and the insertion of a table of contents and headings are for the convenience of reference only and do not affect
the construction or interpretation of this Agreement. The terms “hereof”, “hereunder” and similar expressions
refer to this Agreement and not to any particular Article, Section or other portion hereof. Unless something in the subject matter
or context is inconsistent therewith, references herein to Articles, Sections and Schedules are to Articles, Sections of and Schedules
to this Agreement.

 

		1.03	Extended Meanings

 

In this Agreement words importing the singular
number only include the plural and vice versa, words importing any gender include all genders and words importing persons include
individuals, corporations, limited and unlimited liability companies, general and limited partnerships, associations, trusts, unincorporated
organizations, joint ventures and governmental authorities. The term “including” means “including without limiting
the generality of the foregoing”.

 

		1.04	Statutory References

 

In this Agreement, unless something in the
subject matter or context is inconsistent therewith or unless otherwise herein provided, a reference to any statute is to that
statute as now enacted or as the same may from time to time be amended, re-enacted or replaced and includes any regulation made
thereunder.

    	4

    	

    

		1.05	Currency

 

All references to currency herein are to
lawful money of the United States.

 

		1.06	Schedules

 

The following Schedule is incorporated by
reference into this Agreement and deemed to form part hereof:

 

Schedule A -            Duties and Responsibilities

 

ARTICLE
2 - EMPLOYMENT

 

		2.01	Employment and Term

 

(1) Subject to the terms and conditions
of this Agreement, the Corporation will continue to employ the Employee in the position of Chief Development Officer.

 

(2) The term of this Agreement and the
Employee’s employment with the Corporation under this Agreement is on an at-will basis and will continue for an indefinite
period, subject to termination in accordance with Article 7 of this Agreement.

 

(3) The Employee will report to the CEO
of the Parent or such other person as may be designated by the Board.

 

(4) In addition to the duties and responsibilities
that are inherent to the position of Chief Development Officer of a corporation and the specific duties and responsibilities set
out in Schedule A, the Employee will perform such other duties and responsibilities as may be assigned to him, from time
to time, by the CEO of the Parent, and the Employee will have the powers and authority to perform such duties and responsibilities,
subject always to the control and direction of the CEO of the Parent.

 

ARTICLE
3 - REMUNERATION AND BENEFITS

 

		3.01	Annual Base Salary

 

(1) The Corporation will pay the Employee
a base salary at the gross annual rate of $265,589 (the “Base Salary”). In the event the Corporation completes
an initial public offering of the Corporation, such Base Salary shall be increased to $290,000 as of the date such initial public
offering is completed. The Base Salary will be payable in equal installments, in accordance with the Corporation’s normal
payroll schedule as in effect from time to time, in arrears and subject to deductions required by law or authorized by the Employee.
Employee hereby authorizes payment of the Base Salary by direct deposit.

 

(2) The Board will review the Base Salary
annually. The Board will be under no obligation to increase the Base Salary.

    	5

    	

    

		3.02	Bonus

 

The Employee will be eligible to receive
an annual incentive bonus (the “Bonus”) of up to 30% of the Employee’s Base Salary to be determined by
the Board in its sole and absolute discretion based on achievement of performance goals established for the Employee and the Corporation
at the beginning of each year and in accordance with the terms of any applicable bonus plan in effect from time to time.

 

		3.03	Performance Review

 

The Corporation will formulate a procedure
for review of the Employee’s performance. Such review will be conducted annually by the Corporation.

 

		3.04	Benefit Plans

 

The Employee will be eligible to participate
in any benefit plans (including any equity based incentive plan of the Corporation) made generally available to the Corporation’s
similarly-situated employees from time to time and based on market comparables, subject to and in accordance with the terms and
conditions of the applicable benefit plans (“Benefit Plans”). The Employee acknowledges that the Benefit Plans
may be amended or terminated from time to time, as provided in the applicable plan, fund or arrangement.

 

		3.05	Vacation

 

The Employee will be entitled to four (4)
weeks of paid vacation per calendar year, to be earned and taken in accordance with the Corporation’s policies as in effect
from time to time. The Employee will take his vacation at a time or times reasonable for each of the Corporation and the Employee
in the circumstances, taking into consideration the business needs of the Corporation.

 

		3.06	Expenses

 

The Corporation will reimburse the Employee
for all reasonable out-of-pocket expenses properly incurred by him in the course of the Employee’s employment with the Corporation
in accordance with the Corporation’s policies as in effect from time to time. The Employee will provide the Corporation with
such statements and receipts verifying such expenses as the Corporation may reasonably require.

 

ARTICLE
4 - EMPLOYEE’S COVENANTS

 

		4.01	Full Time Service

 

The Employee will devote all of his working
time, attention and effort to the business and affairs of the Corporation and will well and faithfully serve the Corporation and
will use his best efforts to promote the interests of the Corporation.

    	6

    	

    

		4.02	Duties and Responsibilities

 

The Employee will duly and diligently perform
all the duties assigned to him while in the employ of the Corporation, and will truly and faithfully account for and deliver to
the Corporation all money, securities and things of value belonging to the Corporation which the Employee may from time to time
receive for, from or on account of the Corporation.

 

		4.03	Rules and Regulations

 

The Employee will be bound by and will faithfully
observe and abide by all the rules and regulations of the Corporation from time to time in force which are brought to his notice
or of which he should reasonably be aware, as amended by the Corporation from time to time. Notwithstanding the foregoing, in the
event of a conflict between rules and regulations and this Agreement, the terms of this Agreement will have precedence.

 

		4.04	Conflict of Interest

 

The Employee will refrain from any situation
in which the Employee’s personal interest conflicts, or may appear to conflict, with the Employee’s duties with the
Corporation. The Employee acknowledges that if there is any doubt in this respect, the Employee will inform the Board and obtain
written authorization.

 

		4.05	Confidential Information

 

(1) The Employee acknowledges that, by
reason of his employment with the Corporation and his prior employment with the Parent, he has and will continue to have access
to Confidential Information. The Employee agrees that, during and after his employment with the Corporation, he will not disclose
to any person, directly or indirectly, disclose, divulge, diffuse, sell, transfer, give, publish, circulate or distribute to any
Person whomsoever or otherwise make public, except in the proper course of his employment with the Corporation, or use for his
own purposes or for any purposes other than those of the Corporation, any Confidential Information acquired by him during his employment
with the Corporation or his prior employment with the Parent.

 

(2) Any breach of Section 4.05(1) by the
Employee will result in material and irreparable harm to the Corporation although it may be difficult for the Corporation to establish
the monetary value flowing from such harm. The Employee therefore agrees that the Corporation, in addition to being entitled to
the monetary damages which flow from the breach and to any other recourse or remedy available to it, will be entitled to injunctive
relief in a court of appropriate jurisdiction in the event of any breach by the Employee of Section 4.05(1) (without the posting
of a bond or other security).

 

	4.06	Permitted Conduct

 

Employee understands that nothing contained
in this Agreement limits Employee’s ability to file a charge or complaint with the Equal Employment Opportunity Commission,
the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission,
or any other federal, state or local governmental agency

    	7

    	

    

or commission (“Government Agencies”).
Employee further understands that this Agreement does not limit Employee’s ability to communicate with any Government Agencies
or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing
documents or other information, without notice to Employer; provided, however, that Employee may not disclose Employer information
that is protected by the attorney-client privilege, except as expressly authorized by law. This Agreement does not limit Employee’s
right to receive an award for information provided to any Government Agencies.

 

	4.07	Defend Trade Secret Act Notice

 

The Company provides notice to Employee that:

 

(1) An individual will not be held criminally
or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (a) is made (i) in confidence
to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose
of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document filed in a lawsuit
or other proceeding, if such filing is made under seal; and

 

(2) An individual who files a lawsuit
for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the
individual and use the trade secret information in the court proceeding, if the individual (a) files any document containing the
trade secret under seal; and (b) does not disclose the trade secret, except pursuant to court order.

 

ARTICLE
5 - RESTRICTIVE COVENANTS

 

		5.01	Non-Competition

 

(1) The Employee shall not, without the
prior written consent of the Corporation, at any time during the term of his employment with the Corporation and during the Severance
Period, regardless of the reason for the termination (but less any notice provided by the Employee pursuant to Section 7.01 of
this Agreement, if applicable), directly or indirectly, in any manner whatsoever including, without limitation, either individually,
or in partnership, jointly or in conjunction with any other Person, or as employee, principal, director, agent or shareholder:

 

		(a)	be engaged in any undertaking;

 

		(b)	have any financial or other interest (including an interest by way of royalty or other compensation arrangements) in or in
respect of the business of any Person; or

 

		(c)	advise, lend money to or guarantee the debts or obligations of any Person which carries on a business;

    	8

    	

    

in the Territory, which is substantially similar to, or which
competes with, the Corporation’s business, namely the development of RARgamma agonists or drugs for Fibrodysplasia Ossificans
Progressiva (FOP) and Multiple Osteochondroma (MO).

 

(2) Nothing in this Section 5.01 shall
prevent the Employee from owning not more than 2% of the issued shares of a corporation, the shares of which are listed on a recognized
stock exchange or traded in the over the counter market in Canada or the United States.

 

		5.02	Non-Solicitation

 

(1) The Employee shall not, without the
prior consent of the Corporation, during the term of his employment or during the Severance Period, regardless of the reason for
the termination (but less any notice provided by the Employee pursuant to Section 7.01 of this Agreement, if applicable), directly
or indirectly:

 

		(a)	solicit any employees of the Corporation or any Affiliate or Subsidiary thereof or induce or attempt to induce any employee
of the Corporation or any Affiliate or Subsidiary thereof to leave his employment; or

 

		(b)	solicit or interfere with the Corporation’s or any Affiliate’s or Subsidiary’s relationships with, or endeavor
to entice away from the Corporation or any

 

 Affiliate or Subsidiary, any Customers
of the Corporation or any Affiliate or

 

		5.03	Subsidiary.

 

Acknowledgement and Breach

 

(1) The covenants contained in Sections
5.01(1) and 5.02(1) are each separate and distinct covenants, severable one from the other and if any such covenant or covenants
are determined to be invalid or unenforceable, such invalidity or unenforceability will attach only to the covenant or covenants
as determined and all other such covenants will continue in full force and effect. Whenever possible, each of the covenants contained
in Sections 5.01(1) and 5.02(1) shall be interpreted in such manner as to be effective and valid under applicable law, but, if
any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule
in any jurisdiction, the parties agree that a court of competent jurisdiction shall have the power to reduce the scope, duration
or area of any such term or provision, to delete specific words or phrases or to replace any invalid or unenforceable term or provision
in Sections 5.01(1) and 5.02(1) with a term or provision that is valid and enforceable and that comes closest to expressing the
intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified.

 

(2) The Employee confirms that all restrictions
in Sections 5.01 and 5.02 are reasonable and valid and that the Employee waives all defenses to the strict enforcement of such
restrictions by the Corporation.

 

(3) Any breach of the provisions of Sections
5.01(1) or 5.02(1) by the Employee will result in material and irreparable harm to the Corporation although it may be difficult
for

    	9

    	

    

the Corporation to establish the monetary
value flowing from such harm. The Employee therefore agrees that the Corporation, in addition to being entitled to the monetary
damages which flow from the breach and to any other recourse or remedy available to it, will be entitled to injunctive relief in
a court of appropriate jurisdiction in the event of any breach or threatened breach by the Employee of any of the provisions of
Sections 5.01(1) or 5.02(1) (without the posting of a bond or other security).

 

(4) The provisions of Sections 5.01(1)
or 5.02(1) of this Agreement shall continue to apply and be valid notwithstanding any change in the Employee’s duties, responsibilities,
position or title.

 

ARTICLE
6 - INVENTIONS AND ASSIGNMENT OF INTELLECTUAL PROPERTY

 

		6.01	Assignment of Corporation Inventions

 

The Employee hereby covenants and agrees
that all Inventions and all Intellectual Property Rights relating thereto shall be the sole and exclusive property of the Corporation.
Where the Corporation is not by law the first and exclusive owner of the Inventions or Intellectual Property Rights relating thereto,
the Employee hereby assigns to the Corporation, without further compensation, all of his present and future rights, title, and
interest in and to any and all present and future Inventions (and all Intellectual Property Rights with respect thereto throughout
the world) made, conceived, reduced to practice, or learned by the Employee, either alone or with others, during the period of
the Employee’s employment by the Corporation, including, without limitation those made, conceived, reduced to practice, or
learned by the Employee with the use of the Corporation’s time, material, private or proprietary information, or facilities
or which are directly or indirectly related to the activities of the Corporation or to the Employee’s employment responsibilities.
Inventions (and all Intellectual Property Rights with respect thereto throughout the world) assigned to the Corporation pursuant
to this Section are referred to in this Agreement as “Corporation Inventions”. In the event that the Employee
is unable to assign any portion of the Corporation Inventions to the Corporation, the Employee hereby grants to the Corporation
an exclusive, perpetual, fully-paid and royalty- free, irrevocable and worldwide license, with rights to assign or sublicense through
multiple levels of sub-licensees, to reproduce, make derivative works of, distribute, communicate to the public by telecommunications,
publicly perform, and publicly display in any form or medium, whether now known or later developed, make, have made, use, sell,
import, offer for sale, and exercise any and all present or future rights in, such Corporation Inventions. The provisions of this
Section 6.01 shall not apply to an invention for which no equipment, supplies, facilities or Confidential Information of the Company
or its Affiliates or Subsidiaries were used and which was developed entirely on the Employee’s own time, unless (i) the invention
relates (A) to the business of the Company or any of its Affiliates or Subsidiaries, or (B) to the Employee’s actual or demonstrably
anticipated research or development for the Company or any of its Affiliates or Subsidiaries, or (ii) the invention results from
any work performed by Employee for the Company or any of its Affiliates or Subsidiaries.

    	10

    	

    

		6.02	Prior Inventions

 

The Employee represents that there are no
Inventions that he has, or has caused to be, alone or jointly with others, conceived, developed, or reduced to practice prior to
the commencement of his employment by the Corporation, in which the Employee has an ownership interest or which the Employee has
a license to use (collectively referred to as “Prior Inventions”) which are directly or indirectly related to
the activities of the Corporation.

 

Should any Prior Inventions become directly
or indirectly related to the activities of the Corporation, the Employee shall so inform the Corporation and further agrees that
she will not incorporate, or permit to be incorporated, such Prior Inventions in any Corporation Inventions without the Corporation’s
prior written consent. If, in the course of the Employee’s employment with the Corporation, the Employee incorporates a Prior
Invention into a Corporation Invention without the Corporation’s prior written consent, the Employee hereby grants the Corporation
an exclusive, perpetual, fully-paid and royalty-free, irrevocable and worldwide license, with rights to assign or sublicense through
multiple levels of sub-licensees, to reproduce, make derivative works of, distribute, communicate to the public by telecommunications,
publicly perform, and publicly display in any form or medium, whether now known or later developed, make, have made, use, sell,
import, offer for sale, and exercise any and all present or future rights in, such Prior Invention.

 

		6.03	Moral Rights

 

The Employee hereby irrevocably waives, for
herself and on behalf of her heirs, estate representatives, successors and assigns, all moral rights she may have in the Corporation
Inventions and in any Prior Inventions (solely to the extent that such Prior Inventions are incorporated into a Corporation Invention
either pursuant to Section 6.02 above or pursuant to a separate written agreement to the Corporation authorizing such incorporation).

 

		6.04	Obligation to Keep Corporation Informed

 

During the period of the Employee’s
employment, the Employee will promptly and fully disclose to the Corporation in writing all Corporation Inventions authored, conceived,
or reduced to practice by the Employee, either alone or with others.

 

		6.05	Enforcement of Intellectual Property Rights and Assistance

 

During the period of the Employee’s
employment and thereafter, the Employee will assist the Corporation in every proper way to obtain, protect and enforce the Intellectual
Property Rights relating to Corporation Inventions in all countries. In the event the Corporation is unable to secure the Employee’s
signature on any document needed in connection with such purposes, the Employee hereby irrevocably designates and appoints the
Corporation and its duly authorized officers and agents as her agent and attorney in fact, which appointment is coupled with an
interest, to act on the Employee’s behalf to execute and file any such documents and to do all other lawfully permitted acts
to further such purposes with the same legal force and effect as if executed by the Employee.

    	11

    	

    

ARTICLE
7 - TERMINATION

 

		7.01	Termination by the Corporation

 

Subject to the requirements of Sections 7.03,
7.04 and 7.05, as applicable, the Corporation may terminate this Agreement and the Employee’s employment with the Corporation
at any time by giving a written notice of termination of the Employee’ employment with the Corporation, delivered in accordance
with Section 8.01, specifying the effective date of the termination (a “Notice of Termination”).

 

		7.02	Termination by the Employee

 

The Employee may terminate this Agreement
and his employment with the Corporation by giving the Corporation 30 days’ prior notice in writing. The Corporation may,
at its discretion, waive all or part of such notice and end the Employee’s employment immediately without liability, payment
or other obligation. The Employee agrees that such waiver will not constitute termination of the Employee’s employment by
the Corporation.

 

		7.03	Payments on Termination Without Cause

 

(1) If the Employee’s employment
with the Corporation is terminated by the Corporation pursuant to Section 7.01 for any reason other than Cause, the Corporation
will:

 

		(a)	pay to the Employee an amount equal to the Base Salary earned by him up to the Date of Termination and any earned but unused
vacation pay calculated as of such date;

 

		(b)	reimburse the Employee in accordance with Section 3.06 for any expenses incurred by him up to and including the Date of Termination;

 

and, subject to and conditional upon the
Employee’s ongoing compliance with the provisions of Section 4.05, Article 5 and Article 6:

 

		(c)	continue to pay to the Employee on the basis outlined in Section 3.01 an amount equivalent to the Base Salary that would have
been payable to him had his employment with the Corporation continued for the Severance Period and such payments will be deemed
to include all notice of termination, termination pay and severance pay that may be owing to the Employee in respect of the termination
of his employment; and

 

		(d)	reimburse the Employee for costs of continuing health care coverage under the Consolidated Omnibus Budget Reconciliation Act
under the applicable Benefit Plans for him and his dependents during the Severance Period.

 

As a condition precedent to any payment or
benefit pursuant to Sections 7.03(1)(c) and (d), the Employee must, within sixty (60) days following the date of the Employee’s
termination of employment, execute a separation agreement containing a general release of the Corporation, the Parent and their
respective Subsidiaries and Affiliates, as well as the then-present and former

    	12

    	

    

employees, officers, directors, agents and
owners of the Corporation, the Parent and their respective Subsidiaries and Affiliates from any and all claims, obligations and
liabilities of any kind whatsoever, including, without limitation, those arising from or in connection with the Employee’s
employment or termination of employment with the Corporation or any of its Subsidiaries or Affiliates or this Agreement (including,
without limitation, civil rights claims), in such form as is requested by the Corporation. If this sixty (60) day period overlaps
two calendar years, any payments shall commence in the later calendar year and any missed payments shall be included in the first
payment commencing in the later calendar year. For the avoidance of doubt, in the event the Employee is entitled to similar payments
under another plan or policy of the Corporation or Parent, the Employee shall receive such payments under the plan, policy or agreement
that provides for the largest amount.

 

		7.04	Payments on Termination by the Corporation for Cause or on Termination by the Employee

 

(1) If the Employee’s employment
with the Corporation is terminated by the Corporation pursuant to Section 7.01 for Cause, or if such employment is terminated by
the Employee pursuant to Section 7.02, the Corporation will:

 

		(a)	pay to the Employee an amount equal to the Base Salary earned by him up to the Date of Termination and any earned but unused
vacation pay calculated as of such date; and

 

		(b)	reimburse the Employee in accordance with Section 3.06 for any expenses incurred by him up to and including the Date of Termination.

 

		7.05	Payments on Termination Without Cause after a Change in Control

 

(1) If the Employee’s employment
with the Corporation is terminated by the Corporation pursuant to Section 7.01 for any reason other than Cause within twelve (12)
months following a Change in Control, the Corporation will:

 

		(a)	pay to the Employee an amount equal to the Base Salary earned by him up to the Date of Termination and any earned but unused
vacation pay calculated as of such date;

 

		(b)	reimburse the Employee in accordance with Section 3.06 for any expenses incurred by him up to and including the Date of Termination;

 

and, subject to and conditional upon the
Employee’s ongoing compliance with the provisions of Section 4.05, Article 5 and Article 6:

 

		(c)	continue to pay to the Employee on the basis outlined in Section 3.01 an amount equivalent to the Base Salary that would have
been payable to him had his employment with the Corporation continued for the Severance Period and such payments will be deemed
to include all notice of termination, termination pay and severance pay that may be owing to the Employee in respect of the termination
of his employment;

    	13

    	

    

		(d)	pay to the Employee the Employee’s target bonus for the year in which the Date of Termination occurs;

 

		(e)	reimburse the Employee for costs of continuing health care coverage under the Consolidated Omnibus Budget Reconciliation Act
under the applicable Benefit Plans for him and his dependents during the Severance Period;

 

		(f)	as of the Date of Termination, fully vest all outstanding equity grants including any outstanding stock options..

 

As a condition precedent to any payment or
benefit pursuant to Sections 7.05(1)(c), (d), (e) and (f), the Employee must, within sixty (60) days following the date of the
Employee’s termination of employment, execute a separation agreement containing a general release of the Corporation, the
Parent and their respective Subsidiaries and Affiliates, as well as the then-present and former employees, officers, directors,
agents and owners of the Corporation, the Parent and their respective Subsidiaries and Affiliates from any and all claims, obligations
and liabilities of any kind whatsoever, including, without limitation, those arising from or in connection with the Employee’s
employment or termination of employment with the Corporation or any of its Subsidiaries or Affiliates or this Agreement (including,
without limitation, civil rights claims), in such form as is requested by the Corporation. If this sixty (60) day period overlaps
two calendar years, any payments shall commence in the later calendar year and any missed payments shall be included in the first
payment commencing in the later calendar year. For the avoidance of doubt, in the event the Employee is entitled to similar payments
under another plan or policy of the Corporation or Parent, the Employee shall receive such payments under the plan, policy or agreement
that provides for the largest amount.

 

		7.06	Fair and Reasonable

 

The Employee acknowledges and agrees that:

 

		(a)	the provisions of Article 7 are fair and reasonable

 

		(b)	the notice or payments or benefits or any combination thereof provided pursuant to this Article 7 will be in full satisfaction
of all rights and obligations resulting from the termination of the Employee’s employment;

 

		(c)	except as provided in this Article 7, the Employee will not be entitled to any further termination payments, damages, or compensation
whatsoever.

 

		7.07	Return of Property

 

Upon any termination of his employment with
the Corporation, or at any other time at the request of the Corporation, the Employee will deliver or cause to be delivered to
the Corporation promptly all books, documents, money, securities or other property of the Corporation that are in the possession,
charge, control or custody of the Employee.

    	14

    	

    

		7.08	Resignation as Director and Officer

 

Upon any termination of the Employee’s
employment under this Agreement, the Employee will be deemed to have resigned, and will, if requested, sign forms of resignation
indicating his resignation, as an officer and director of the Corporation and, if applicable, of any of its Affiliates. The Employee’s
execution of this Agreement shall be deemed the grant by the Employee to the officers of the Corporation of a limited irrevocable
power of attorney (which is deemed coupled with an interest) to sign in the Employee’s name and on the Employee’s behalf
any such documentation as may be required to be executed solely for the limited purposes of effectuating such resignations.

 

		7.09	Provisions which Operate Following Termination

 

Notwithstanding any termination of the Employee’s
employment under this Agreement for any reason whatsoever and with or without Cause, the provisions of Section 4.05 and Articles
5 and 6 of this Agreement and any other provisions of this Agreement necessary to give efficacy thereto will continue in full force
and effect following such termination.

 

ARTICLE
8 - GENERAL

 

		8.01	Notices

 

Any demand, notice or other communication
(“Communication”) to be given in connection with this Agreement will be given in writing by personal delivery,
by registered mail or by electronic means of communication addressed to the recipient as follows:

 

To the Corporation:

 

Clementia Pharmaceuticals U.S.A. Inc.

275 Grove Street, Suite 2-400,

Newton MA 02466

 

Attention: Dr. Donna Grogan

 

Fax: 1-888-966-0135

 

To the Employee:

 

or such other address, individual or electronic communication
number as may be designated by notice given by either party to the other. Any Communication given by personal delivery will be
conclusively deemed to have been given on the day of actual delivery of the Communication and, if given by registered mail, on
the third day following the deposit of the Communication in the mail (provided that if such third day is not a Business Day, then
it will be deemed to have been given on the next succeeding day that is a Business Day), and, if

    	15

    	

    

given by electronic communication, on the day of transmittal
of the Communication if given during the normal business hours of the recipient and on the Business Day during which such normal
business hours next occur if not given during such hours on any day. If the party giving any Communication knows or ought reasonably
to know of any difficulties with the postal system which might affect the delivery of mail, any such Communication may not be mailed
but must be given by personal delivery or by electronic communication.

 

		8.02	Time of Essence

 

Time will be of the essence of this Agreement.

 

		8.03	Deductions

 

The Corporation will deduct all statutory
deductions from any amounts to be paid to the Employee under this Agreement.

 

		8.04	Benefit of Agreement

 

This Agreement will enure to the benefit
of and be binding upon the heirs, executors, administrators and legal personal representatives of the Employee and the successors
and permitted assigns of the Corporation respectively.

 

		8.05	Entire Agreement

 

This Agreement constitutes the entire agreement
between the parties with respect to the Employee’s employment with the Corporation and cancels and supersedes any prior understandings
and agreements between the parties with respect to the Employee’s employment with the Corporation, including the Offer of
Employment and the Employment Agreement. There are no representations, warranties, forms, conditions, undertakings or collateral
agreements, express, implied or statutory between the parties with respect to the Employee’s employment with the Corporation
other than as expressly set forth in this Agreement.

 

		8.06	Pre-Contractual Representations

 

The Employee hereby waives any right to assert
a claim based on any pre- contractual representations, negligent or otherwise, made by the Corporation.

 

		8.07	Amendments and Waivers

 

No amendment to this Agreement will be valid
or binding unless set forth in writing and duly executed by both of the parties to this Agreement. No waiver of any breach of any
provision of this Agreement will be effective or binding unless made in writing and signed by the party purporting to give the
same and, unless otherwise provided in the written waiver, will be limited to the specific breach waived.

    	16

    	

    

		8.08	Section 409A.

 

(a) To the extent applicable, it is intended
that this Agreement will be exempt from or in compliance with Section 409A of the Internal Revenue Code (the “Code”).
This Agreement shall be interpreted in a manner consistent with this intent. Notwithstanding anything in this Agreement to the
contrary, to the extent that any amount or benefit that would constitute non-exempt “deferred compensation” for purposes
of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) would otherwise be payable or distributable
hereunder by reason of Employee’s termination of employment, such amount or benefit will not be payable or distributable
to Employee unless (i) the circumstances giving rise to such termination of employment meet any description or definition of “separation
from service” in Section 409A (without giving effect to any elective provisions that may be available under such definition),
or (ii) the payment or distribution of such amount or benefit would be exempt from the application of Section 409A by reason of
the short-term deferral exemption or otherwise. As determined by the Corporation, to the extent any provision of this Agreement,
or any other agreement with the Corporation or Parent, constitutes a “nonqualified deferred compensation plan” within
the meaning of Section 409A(d)(1) which provides payments to the Employee upon his “separation from service” within
the meaning of Section 409A(a)(2)(A)(i) of the Code, and the Employee is a “specified employee” within the meaning
of Section 409A(a)(2)(B)(i) of the Code at the time of such separation, then any such payment shall commence on the date that is
six months after the date of the Employee’s separation from service and any amounts withheld during such six-month period
shall be paid once benefits commence. The right to a series of installment payments hereunder is treated as a right to a series
of separate payments, subject to the six-month delay rule described immediately above. Subject to the six-month delay described
immediately above, severance or bridging pay will be paid in accordance with normal payroll practices following the Employee’s
separation from service. No provision in this Agreement or any other nonqualified deferred compensation arrangement in which the
Employee participates shall be interpreted or construed to directly or indirectly transfer any liability for a failure to comply
with Section 409A of the Code from the Employee or any other individual to the Corporation, or any other individual or entity affiliated
with the Corporation, and in no event shall the Corporation or any other individual or entity affiliated with the Corporation be
liable for any additional tax, interest or penalties that may be imposed on the Employee as a result of Section 409A of the Code
or any damages for failing to comply with Section 409A of the Code.

 

		8.09	Conditional Cap on Change in Control Benefits

 

(1) If the Employee is a “disqualified
individual” (as defined in Section 280G of the Code), and if the payments and benefits to the Employee pursuant to this Agreement
(when considered with all other payments and benefits made to the Employee which are “parachute payments” as defined
in Section 280G of the Code) (the amount of all such payments, collectively, the “Parachute Payment”) result
in the Employee becoming liable for the payment of any excise taxes pursuant to Section 4999 of the Code (“280G Excise
Tax”), the Employee will receive the greater on an after-tax basis of (a) all Parachute Payments or (b) the Parachute

    	17

    	

    

Payments as reduced to avoid imposition of
the 280G Excise Tax (the “Conditional Capped Amount”).

 

(2) Not more than fourteen (14) days following
a Change in Control, the Corporation will notify the Employee in writing (i) whether the Parachute Payments exceed an amount equal
to 299% (the “299% Amount”) of the Employee’s “base amount” as defined in Section 280G(b)(3)
of the Code, (B) the amount that is equal to the 299% Amount, (C) whether all Parachute Payments or the Conditional Capped Amount
pursuant to Section 8.09(1)(a) is greater on an after-tax basis and (C) if the Conditional Capped Amount is the greater amount,
the amount that the Parachute Payments must be reduced to equal such amount. Such reduction order may be elected by the Executive
at the time to the extent legally permitted and not a violation of Code Section 280G or 409A and, if it is or is not elected within
ten (10) days of the notification, it shall be done in the following order: (a) all cash severance in the reverse order to be received,
(b) all equity valued without regard to Treas. Reg. §1.280G-1, Q&A-24(c) in reverse order of vesting, and (c) all equity
valued pursuant to Treas. Reg. §1.280G-1, Q&A-24(c) in reverse order of vesting.

 

(3) The calculation of the 299% Amount,
the determination of whether the Parachute Payments or the Conditional Capped Amount is greater on an after-tax basis and, if the
Conditional Capped Amount is the greater amount, the determination of how much the Employee’s payments and benefits must
be reduced in order to avoid application of the 280G Excise Tax will be made by the Corporation’s public accounting firm
in accordance with Section 280G of the Code or any successor provision thereto. The costs of obtaining such determination will
be borne by the Corporation; provided that the Corporation shall consult regularly with the Employee on this process and shall
make the Corporation’s public accounting firm or other consultants available to him.

 

		8.10	Severability

 

If any provision of this Agreement is determined
to be invalid or unenforceable in whole or in part, such invalidity or unenforceability will attach only to such provision or part
of such provision and the remaining part of such provision and all other provisions of this Agreement will continue in full force
and effect.

 

		8.11	Governing Law

 

This Agreement will be governed by and construed
in accordance with the laws of the State of Massachusetts without regard to conflict of laws provisions.

 

		8.12	Jurisdiction

 

For the purpose of all legal proceedings
this Agreement will be deemed to have been performed in the State of Massachusetts and the courts of the State of Massachusetts
will have jurisdiction to entertain any action arising under this Agreement. The Corporation and the Employee each hereby agrees
to the jurisdiction of the courts of the State of Massachusetts.

    	18

    	

    

		8.13	Copy of Agreement

 

The Employee hereby acknowledges receipt
of a copy of this Agreement duly signed by the Corporation.

 

[Signature page follows]

    	19

    	

    

IN WITNESS WHEREOF the parties have executed
this Agreement.

 

	 	 	CLEMENTIA PHARMACEUTICALS U.S.A. INC.
	 	 	   	                         
	 	 	By: 

	 	 	Name:	Dr. Donna Roy Grogan
	 	 	Title:	President
	 	 	 	 
	WITNESS:	 	 	 
	 	 	 	 
	 	 	 	 
	Signature	 	MR. JEFF PACKMAN
	 	 	 	 
	 	 	 	 
	Name (Please print)	 	 	 

    	 

    	

    

SCHEDULE
A

 

JOB DESCRIPTION

 

Chief Development Officer

 

		Ÿ	Overall responsibility
                                                                                                            for regulatory, clinical
                                                                                                            operations and manufacturing
                                                                                                            activities

 

		Ÿ	Develop and/or
                                                                                                            further refine regulatory
                                                                                                            strategy, both in
                                                                                                            US and ex-US regions

 

		Ÿ	Responsible for
                                                                                                            overall Program Management
                                                                                                            for all research and
                                                                                                            development programs
                                                                                                            in Clementia, including
                                                                                                            determination and
                                                                                                            maintenance of timelines
                                                                                                            and budgets

 

		Ÿ	Responsible for
                                                                                                            the CMC and non-clinical
                                                                                                            content of all regulatory
                                                                                                            documents, including
                                                                                                            protocols, investigator
                                                                                                            brochures, annual
                                                                                                            IND reports, and clinical
                                                                                                            study reports

 

		Ÿ	Ensure adequate
                                                                                                            QA/QC oversight of
                                                                                                            development activities
                                                                                                            to support registration;
                                                                                                            responsible for GMP,
                                                                                                            GLP and GCP compliance,
                                                                                                            including training
                                                                                                            activities and documentation

 

		Ÿ	Ensure adequate
                                                                                                            clinical supplies
                                                                                                            are available to execute
                                                                                                            both clinical and
                                                                                                            non-clinical program

 

		Ÿ	Ensure adequate
                                                                                                            resources, both internally
                                                                                                            and externally to
                                                                                                            accomplish goals and
                                                                                                            objectives of the
                                                                                                            organization

 

		Ÿ	Recognize the
                                                                                                            unique needs of Clinical
                                                                                                            Development for rare
                                                                                                            diseases and seek
                                                                                                            to identity ways to
                                                                                                            shorten timelines,
                                                                                                            including utilization
                                                                                                            of adaptive clinical
                                                                                                            trial designs

 

		Ÿ	Establish a collegial
                                                                                                            culture that promotes
                                                                                                            flexibility, creativity
                                                                                                            in problem solving,
                                                                                                            and receptivity to
                                                                                                            the ideas of others

 

		Ÿ	Serve as a member
                                                                                                            of the Clementia Executive
                                                                                                            Leadership Team to
                                                                                                            influence the future
                                                                                                            strategy of the company,
                                                                                                            fuel planning, drive
                                                                                                            organizational development,
                                                                                                            ensure appropriate
                                                                                                            funding and advance
                                                                                                            the R&D effortsExhibit 10.16

 

AMENDed
and restated

 

EMPLOYMENT
AGREEMENT

 

BETWEEN

 

CLEMENTIA
PHARMACEUTICALS INC.

 

AND

 

MR. MICHAEL
SINGER

 

MADE AS
OF                     , 2017

    	 

    	

    

amended
and restated EMPLOYMENT AGREEMENT

 

THIS AGREEMENT is made as of                      , 2017,

 

B E T W E E N:

 

CLEMENTIA PHARMACEUTICALS INC.,
a corporation incorporated under the laws of Canada, having its head office at 4150 Sainte-Catherine Street West, Suite 550, Montreal,
Quebec, H3Z 2YA, Canada, herein acting and represented by Dr. Clarissa Desjardins, President and Chief Executive Officer, duly
authorized for the purposes hereof as she so declares (the “Corporation”),

 

A N D:

 

MR. MICHAEL SINGER, domiciled
and residing at                                    

(the “Employee”),

 

WHEREAS the Employee
has been employed by the Corporation since May 1, 2015 pursuant to an offer letter dated March 23, 2015 (the “Offer of
Employment”);

 

WHEREAS the Corporation
and the Employee are parties or an Employment Agreement made as of August 28, 2015 (the “Employment Agreement”)

 

WHEREAS the Corporation
wishes to continue to employ the Employee and the Employee wishes to provide services to the Corporation on the terms and conditions
set forth in this Agreement;

 

NOW, THEREFORE,
in consideration of the mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

Article
1 - INTERPRETATION

 

	1.01	Definition of Certain Terms

 

In this Agreement, unless
something in the subject matter or context is inconsistent therewith:

 

“Affiliate” of any Person
shall mean any other Person directly or indirectly controlling, controlled by, or under common control with, such Person; provided,
that, for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlled
by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the
ownership of voting securities, by contract or otherwise.

 

“Agreement” means this
agreement, including its recitals and schedules, as amended from time to time.

    	2

    	

    

“Base Salary” has the
meaning attributed thereto in Section 3.01 of this Agreement.

 

“Benefit Plans” has
the meaning attributed thereto in Section 3.04 of this Agreement.

 

“Board” means the board
of directors of the Corporation in office from time to time.

 

“Business Day” means
any day other than a Saturday, Sunday or statutory or civic holiday in the Province of Quebec.

 

“Cause” means: (i) any
theft, fraud, dishonesty, or serious misconduct by the Employee involving the property, business or affairs of the Corporation
or its Affiliates or the carrying out of the Employee’s duties, (ii) any material breach or non-observance by the Employee
of any term of this Agreement, including gross negligence and failure or refusal to perform his duties or responsibilities, which
breach or non-observance is not cured, to the extent susceptible to cure, within fourteen (14) days after having been notified
of such by the Corporation, (iii) any act by the Employee constituting a criminal offence which is incompatible with the Employee’s
duties and responsibilities, whether such offence is indictable or punishable on summary conviction or otherwise involving theft,
fraud, dishonesty, misrepresentation or moral turpitude, (iv) breach of fiduciary duty, conflict of interest or self-dealing, gross
negligence, willful misconduct or willful insubordination; or (v) violation of policies or procedures of the Company or its Affiliates,
as applicable, which is detrimental to the business, reputation, character or standing of the Corporation or any of its Affiliates;
or (vi) any other action recognized as “just and sufficient cause” or “serious reason” under applicable
laws.

 

“CEO” means Chief Executive
Officer.

 

“Change in Control”
has the meaning set forth in the Corporation’s 2017 Omnibus Incentive Plan.

 

“Confidential Information”
means confidential information of the Corporation, or any Affiliate or Subsidiary thereof, including trade secrets, customer lists,
Inventions, research results, research developments, data and materials supporting research results and research developments and
other confidential information concerning the business and affairs of the Corporation or any Affiliate or Subsidiary thereof.

 

“Customer” means any
Person having purchased goods or services from the Corporation in connection with the Corporation’s business, namely the
development of RARgamma agonists or drugs for Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma (MO), at
any time during the two years preceding the termination of the Employee’s employment with the Corporation or with whom the
Corporation is in negotiation at the time the Employee’s employment ends with a view to selling or providing goods or services,
in connection with the Corporation’s business, to such Person.

 

“Date of Termination”
means:

 

		(a)	if the Employee’s employment with the Corporation is terminated by the Employee in accordance
with Section 7.02, or due to the death, incapacity or retirement of the Employee, or for any other reason not otherwise

    	3

    	

    

contemplated
by Article 7, the last day of the Employee’s active employment with the Corporation; or

 

		(b)	if the Employee’ employment with the Corporation is terminated by the Corporation in accordance
with Section 7.01, for any reason whatsoever, with or without Cause, the date specified in the Notice of Termination.

 

“Employment Agreement”
has the meaning attributed to it in the recitals.

 

“Intellectual Property Rights”
means all trade secrets, copyrights, trade-marks, domain names, industrial designs, mask work rights, rights in integrated circuit
topographies, patents and other intellectual property rights recognized by the laws of any jurisdiction or country, including applications,
registrations, titles, renewals, issues, re-issues and extensions of the rights thereto.

 

“Invention” means any
ideas, concepts, devices, algorithms, information, materials, methods, processes, data, computer programs, databases, know-how,
discoveries, developments, designs, images, artwork, formulae, other copyrightable works, and techniques, including any enhancements,
modifications or additions thereto and/or to the products owned, licensed, sold, marketed or used by the Corporation, whether patentable
or not, and all Intellectual Property Rights therein.

 

“Notice of Termination” has the meaning set
forth in Section 7.01 of this Agreement.

 

“Person” is to be broadly
interpreted and includes an individual, a partnership, a corporation, a trust, a joint venture, any governmental authority or any
incorporated or unincorporated entity or association of any nature and the executors, administrators, or other legal representatives
of an individual in such capacity.

 

“Same or Similar Capacity” means:

 

		(i)	the same or similar capacity or function in which the Employee worked for the Corporation at any time
during the last two years of the Employee’s employment;

 

		(ii)	any executive or managerial capacity; and/or

 

		(iii)	a capacity of partner, trustee, lender or shareholder.

 

“Severance Period” means
the period beginning on the Date of Termination and ending after a period equal to nine (9) months following the Date of Termination.

 

“Subsidiary” with respect
to any Person, shall mean (a) any corporation more than fifty percent (50%) of the stock of any class or classes of which having
by the terms thereof ordinary voting power to elect a majority of the directors of such corporation (irrespective of whether or
not at the time stock of any class or classes of such corporation shall have or might have voting power by reason of the happening
of any contingency) is owned by such Person directly or indirectly through one or more subsidiaries of such Person and (b) any
partnership, association, joint venture, limited liability company or other entity in which such Person directly or indirectly

    	4

    	

    

through one or more subsidiaries of such
Person has more than a fifty percent (50%) equity interest.

 

“Territory” means the
United States and Canada.

 

	1.02	Headings

 

The division of this
Agreement into Articles and Sections and the insertion of a table of contents and headings are for the convenience of reference
only and do not affect the construction or interpretation of this Agreement. The terms “hereof”, “hereunder”
and similar expressions refer to this Agreement and not to any particular Article, Section or other portion hereof. Unless something
in the subject matter or context is inconsistent therewith, references herein to Articles, Sections and Schedules are to Articles,
Sections of and Schedules to this Agreement.

 

	1.03	Extended Meanings

 

In this Agreement words
importing the singular number only include the plural and vice versa, words importing any gender include all genders and words
importing persons include individuals, corporations, limited and unlimited liability companies, general and limited partnerships,
associations, trusts, unincorporated organizations, joint ventures and governmental authorities. The term “including”
means “including without limiting the generality of the foregoing”.

 

	1.04	Statutory References

 

In this Agreement, unless
something in the subject matter or context is inconsistent therewith or unless otherwise herein provided, a reference to any statute
is to that statute as now enacted or as the same may from time to time be amended, re-enacted or replaced and includes any regulation
made thereunder.

 

	1.05	Currency

 

All references to currency
herein are to lawful money of the Canada.

 

	1.06	Schedules

 

The following Schedules
are incorporated by reference into this Agreement and deemed to form part hereof:

 

Schedule A - Duties
and Responsibilities

 

Schedule B - Permitted
Outside Duties

    	5

    	

    

Article
2 - EMPLOYMENT

 

	2.01	Employment and Term

 

(1) Subject to the
terms and conditions of this Agreement, the Corporation will continue to employ the Employee in the position of Chief Financial
Officer.

 

(2) The term of this
Agreement and the Employee’s employment with the Corporation under this Agreement will continue for an indefinite period,
subject to termination in accordance with Article 7 of this Agreement.

 

(3) The Employee
will report to the CEO or such other person as may be designated by the Board.

 

(4) In addition to
the duties and responsibilities that are inherent to the position of Chief Financial Officer of a corporation and the specific
duties and responsibilities set out in Schedule A, the Employee will perform such other duties and responsibilities as may be assigned
to him, from time to time, by the CEO or the Board, and the Employee will have the powers and authority to perform such duties
and responsibilities, subject always to the control and direction of the CEO and the Board.

 

Article
3 - REMUNERATION AND BENEFITS

 

	3.01	Annual Base Salary

 

(1) The Corporation
will pay the Employee a base salary at the gross annual rate of $290,000 (the “Base Salary”). In the event the
Corporation completes an initial public offering of the Corporation, such Base Salary shall be increased to $331,000 as of the
date such initial public offering is completed. The Base Salary will be payable in equal installments, in accordance with the Corporation’s
normal payroll schedule as in effect from time to time, in arrears by direct deposit and subject to deductions required by law
or authorized by the Employee.

 

(2) The Board will
review the Base Salary annually and may increase, but not decrease (except when decreases that are being implemented throughout
the Corporation, provided the decrease in the Employee’s Base Salary is proportional to decreases of the compensation of
the other Corporation employees), the Base Salary upon approval by the Board. The Board will be under no obligation to increase
the Base Salary.

 

	3.02	Bonus

 

The Employee will be
eligible to receive an annual incentive bonus (the “Bonus”) of up to 30% of the Employee’s Base Salary
to be determined by the Board in its sole and absolute discretion based on achievement of performance goals established for the
Employee and the Corporation at the beginning of each year and in accordance with the terms of any applicable bonus plan in effect
from time to time.

 

	3.03	Performance Review

 

The Corporation will
formulate a procedure for review of the Employee’s performance. Such review will be conducted annually by the Corporation.

    	6

    	

    

	3.04	Benefit Plans

 

The Employee will be
eligible to participate in any benefit plans (including any equity based incentive plan of the Corporation) made generally available
to the Corporation’s similarly-situated employees from time to time and based on market comparables, subject to and in accordance
with the terms and conditions of the applicable benefit plans (“Benefit Plans”). The Employee acknowledges that
the Benefit Plans may be amended or terminated from time to time, as provided in the applicable plan, fund or arrangement.

 

	3.05	Vacation

 

The Employee will be
entitled to four (4) weeks of paid vacation per calendar year, to be earned and taken in accordance with the Corporation’s
policies as in effect from time to time. The Employee will take his vacation at a time or times reasonable for each of the Corporation
and the Employee in the circumstances, taking into consideration the business needs of the Corporation.

 

	3.06	Expenses

 

The Corporation will
reimburse the Employee for all reasonable out-of-pocket expenses properly incurred by him in the course of the Employee’s
employment with the Corporation in accordance with the Corporation’s policies as in effect from time to time. The Employee
will provide the Corporation with such statements and receipts verifying such expenses as the Corporation may reasonably require.

 

Article
4 - EMPLOYEE’S COVENANTS

 

	4.01	Full Time Service

 

The Employee will devote
all of his working time, attention and effort to the business and affairs of the Corporation and will well and faithfully serve
the Corporation and will use his best efforts to promote the interests of the Corporation. The Employee may however continue to
act as consultant, director and or committee member as disclosed under Schedule B, subject to the terms and conditions of Article
5 hereof and as long as such activities do not affect the performance of his functions as Chief Financial Officer of the Corporation.

 

	4.02	Duties and Responsibilities

 

The Employee will duly
and diligently perform all the duties assigned to him while in the employ of the Corporation, and will truly and faithfully account
for and deliver to the Corporation all money, securities and things of value belonging to the Corporation which the Employee may
from time to time receive for, from or on account of the Corporation.

 

	4.03	Rules and Regulations

 

The Employee will be
bound by and will faithfully observe and abide by all the rules and regulations of the Corporation from time to time in force which
are brought to his notice or of which he should reasonably be aware, as amended by the Corporation from time to

    	7

    	

    

time. Notwithstanding
the foregoing, in the event of a conflict between rules and regulations and this Agreement, the terms of this Agreement will have
precedence.

 

	4.04	Conflict of Interest

 

The Employee will refrain
from any situation in which the Employee’s personal interest conflicts, or may appear to conflict, with the Employee’s
duties with the Corporation. The Employee acknowledges that if there is any doubt in this respect, the Employee will inform the
Board and obtain written authorization.

 

	4.05	Confidential Information

 

(1) The Employee
acknowledges that, by reason of his employment with the Corporation he has and will continue to have access to Confidential Information.
The Employee agrees that, during his employment with the Corporation and for a period of 36 months following the Date of Termination,
he will not disclose to any person, directly or indirectly, disclose, divulge, diffuse, sell, transfer, give, publish, circulate
or distribute to any Person whomsoever or otherwise make public, except in the proper course of his employment with the Corporation,
or use for his own purposes or for any purposes other than those of the Corporation, any Confidential Information acquired by him
during his employment with the Corporation. Notwithstanding the above 36 month period, the foregoing restrictions shall continue
permanently after the termination of the Employee’s employment with the Corporation where the Confidential Information concerns
the reputation and private life of another person and any commercial secret, invention or proposed trademark of the Corporation

 

(2) Any breach of
Section 4.05(1) by the Employee will result in material and irreparable harm to the Corporation although it may be difficult for
the Corporation to establish the monetary value flowing from such harm. The Employee therefore agrees that the Corporation, in
addition to being entitled to the monetary damages which flow from the breach and to any other recourse or remedy available to
it, will be entitled to injunctive relief in a court of appropriate jurisdiction in the event of any breach by the Employee of
Section 4.05(1) (without posting of a bond or other security).

 

Article
5 - RESTRICTIVE COVENANTS

 

	5.01	Non-Competition

 

The Employee shall not, without the prior
written consent of the Corporation, at any time during the term of his employment with the Corporation, without limitation of a
geographical area, and during the Severance Period, anywhere within the Territory, directly or indirectly, in a Same or Similar
Capacity, either individually, or in partnership, jointly or in conjunction with any other Person, carry on or be engaged, be employed
by or consult with any business, undertaking or activity which competes, in whole or in part, with the Corporation’s business,
namely the development of RARgamma agonists or drugs for Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma
(MO). Nothing in this Section 5.01 shall prevent the Employee from owning not more than 2% of the issued shares of a corporation,
the shares of which are listed on a recognized stock exchange or traded in the over the counter market in Canada or the United
States.

    	8

    	

    

	5.02	Non-Solicitation

 

(1) The Employee
shall not, without the prior consent of the Corporation, during the term of his employment and during the Severance Period, directly
or indirectly, either individually, or in partnership, jointly or in conjunction with any other Person:

 

		(a)	solicit or hire any employee of the Corporation or of any Affiliate or Subsidiary thereof or induce
or attempt to induce any employee of the Corporation or of any Affiliate or Subsidiary thereof to leave his employment; or

 

		(b)	solicit or interfere with the Corporation’s or any Affiliate’s or Subsidiary’s
relationships with, or endeavour to entice away from the Corporation or any Affiliate or Subsidiary, any Customers of the Corporation
or any Affiliate or Subsidiary.

 

	5.03	Acknowledgement and Breach

 

(1) The covenants
contained in Sections 5.01(1) and 5.02(1) are each separate and distinct covenants, severable one from the other and if any such
covenant or covenants are determined to be invalid or unenforceable, such invalidity or unenforceability will attach only to the
covenant or covenants as determined and all other such covenants will continue in full force and effect.

 

(2) The Employee
confirms that all restrictions in Sections 5.01 and 5.02 are reasonable and valid and that the Employee waives all defences to
the strict enforcement of such restrictions by the Corporation.

 

(3) Any breach of
the provisions of Sections 5.01(1) or 5.02(1) by the Employee will result in material and irreparable harm to the Corporation although
it may be difficult for the Corporation to establish the monetary value flowing from such harm. The Employee therefore agrees that
the Corporation, in addition to being entitled to the monetary damages which flow from the breach and to any other recourse or
remedy available to it, will be entitled to injunctive relief in a court of appropriate jurisdiction in the event of any breach
or threatened breach by the Employee of any of the provisions of Sections 5.01(1) or 5.02(1) (without posting of a bond or other
security).

 

(4) The provisions
of Sections 5.01(1) or 5.02(1) of this Agreement shall continue to apply and be valid notwithstanding any change in the Employee’s
duties, responsibilities, position or title.

 

Article
6 - INVENTIONS AND ASSIGNMENT OF INTELLECTUAL PROPERTY

 

	6.01	Assignment of Corporation Inventions

 

The Employee hereby
covenants and agrees that all Inventions and all Intellectual Property Rights relating thereto shall be the sole and exclusive
property of the Corporation. Where the Corporation is not by law the first and exclusive owner of the Inventions or

    	9

    	

    

Intellectual Property
Rights relating thereto, the Employee hereby assigns to the Corporation, without further compensation, all of his present and future
rights, title, and interest in and to any and all present and future Inventions (and all Intellectual Property Rights with respect
thereto throughout the world) made, conceived, reduced to practice, or learned by the Employee, either alone or with others, during
the period of the Employee’s employment by the Corporation, including, without limitation those made, conceived, reduced
to practice, or learned by the Employee with the use of the Corporation’s time, material, private or proprietary information,
or facilities or which are directly or indirectly related to the activities of the Corporation or to the Employee’s employment
responsibilities. Inventions (and all Intellectual Property Rights with respect thereto throughout the world) assigned to the Corporation
pursuant to this Section are referred to in this Agreement as “Corporation Inventions”. In the event that the
Employee is unable to assign any portion of the Corporation Inventions to the Corporation, the Employee hereby grants to the Corporation
an exclusive, perpetual, fully-paid and royalty-free, irrevocable and worldwide license, with rights to assign or sublicense through
multiple levels of sub-licensees, to reproduce, make derivative works of, distribute, communicate to the public by telecommunications,
publicly perform, and publicly display in any form or medium, whether now known or later developed, make, have made, use, sell,
import, offer for sale, and exercise any and all present or future rights in, such Corporation Inventions.

 

	6.02	Prior Inventions

 

The Employee represents
that there are no Inventions that he has, or has caused to be, alone or jointly with others, conceived, developed, or reduced to
practice prior to the commencement of his employment by the Corporation, in which the Employee has an ownership interest or which
the Employee has a license to use (collectively referred to as “Prior Inventions”) which are directly or indirectly
related to the activities of the Corporation.

 

Should any Prior Inventions
become directly or indirectly related to the activities of the Corporation, the Employee shall so inform the Corporation and further
agrees that she will not incorporate, or permit to be incorporated, such Prior Inventions in any Corporation Inventions without
the Corporation’s prior written consent. If, in the course of the Employee’s employment with the Corporation, the Employee
incorporates a Prior Invention into a Corporation Invention without the Corporation’s prior written consent, the Employee
hereby grants the Corporation an exclusive, perpetual, fully-paid and royalty-free, irrevocable and worldwide license, with rights
to assign or sublicense through multiple levels of sub-licensees, to reproduce, make derivative works of, distribute, communicate
to the public by telecommunications, publicly perform, and publicly display in any form or medium, whether now known or later developed,
make, have made, use, sell, import, offer for sale, and exercise any and all present or future rights in, such Prior Invention.

 

	6.03	Moral Rights

 

The Employee hereby
irrevocably waives, for herself and on behalf of her heirs, estate representatives, successors and assigns, all moral rights she
may have in the Corporation Inventions and in any Prior Inventions (solely to the extent that such Prior Inventions are incorporated
into a Corporation Invention either pursuant to Section 6.02 above or pursuant to a separate written agreement to the Corporation
authorizing such incorporation).

    	10

    	

    

	6.04	Obligation to Keep Corporation Informed

 

During the period of
the Employee’s employment, the Employee will promptly and fully disclose to the Corporation in writing all Corporation Inventions
authored, conceived, or reduced to practice by the Employee, either alone or with others.

 

	6.05	Enforcement of Intellectual Property Rights and Assistance

 

During the period of
the Employee’s employment and thereafter, the Employee will assist the Corporation in every proper way to obtain, protect
and enforce the Intellectual Property Rights relating to Corporation Inventions in all countries. In the event the Corporation
is unable to secure the Employee’s signature on any document needed in connection with such purposes, the Employee hereby
irrevocably designates and appoints the Corporation and its duly authorized officers and agents as her agent and attorney in fact,
which appointment is coupled with an interest, to act on the Employee’s behalf to execute and file any such documents and
to do all other lawfully permitted acts to further such purposes with the same legal force and effect as if executed by the Employee.

 

Article
7 - TERMINATION

 

	7.01	Termination by the Corporation

 

Subject to the requirements
of Sections 7.03, 7.04 and 7.05, as applicable, the Corporation may terminate this Agreement and the Employee’s employment
with the Corporation at any time by giving a written notice of termination of the Employee’ employment with the Corporation,
delivered in accordance with Section 8.01, specifying the effective date of the termination (a “Notice of Termination”).

 

	7.02	Termination by the Employee

 

The Employee may terminate
this Agreement and his employment with the Corporation by giving the Corporation 30 days’ prior notice in writing. The Corporation
may, at its discretion, waive all or part of such notice and end the Employee’s employment immediately by providing the Employee
with pay in lieu of notice until the end of the Employee’s resignation notice period.

 

	7.03	Payments on Termination Without Cause

 

(1) If the Employee’s
employment with the Corporation is terminated by the Corporation pursuant to Section 7.01 for any reason other than Cause, the
Corporation will:

 

		(a)	pay to the Employee an amount equal to the Base Salary earned by him up to the Date of Termination
and any earned but unused vacation pay calculated as of such date;

 

		(b)	reimburse the Employee in accordance with Section 3.06 for any expenses incurred by him up to and
including the Date of Termination;

    	11

    	

    

		(c)	continue to pay to the Employee on the basis outlined in Section 3.01 an amount equivalent to the
Base Salary that would have been payable to him had his employment with the Corporation continued for the Severance Period; and

 

		(d)	reimburse the Employee for costs of continuing health care coverage under the applicable Benefit
Plans for him and his dependents during the Severance Period.

 

		7.04	Payments on Termination by the Corporation for Cause or on Termination by the Employee

 

(1) If the Employee’s
employment with the Corporation is terminated by the Corporation pursuant to Section 7.01 for Cause, or if such employment is terminated
by the Employee pursuant to Section 7.02, the Corporation will:

 

		(a)	pay to the Employee an amount equal to the Base Salary earned by him up to the Date of Termination
and any earned but unused vacation pay calculated as of such date; and

 

		(b)	reimburse the Employee in accordance with Section 3.06 for any expenses incurred by him up to and
including the Date of Termination.

 

		7.05	Payments on Termination Without Cause after a Change in Control

 

(1) If the Employee’s
employment with the Corporation is terminated by the Corporation pursuant to Section 7.01 for any reason other than Cause within
twelve (12) months following a Change in Control, the Corporation will:

 

		(a)	pay to the Employee an amount equal to the Base Salary earned by her up to the Date of Termination
and any earned but unused vacation pay calculated as of such date;

 

		(b)	reimburse the Employee in accordance with Section 3.06 for any expenses incurred by her up to and
including the Date of Termination;

 

		(c)	continue to pay to the Employee on the basis outlined in Section 3.01 an amount equivalent to the
Base Salary that would have been payable to her had her employment with the Corporation continued for the Severance Period;

 

		(d)	pay to the Employee the Employee’s target bonus for the year in which the Date of Termination
occurs within thirty (30) days after the Date of Termination;

 

		(e)	reimburse the Employee for the cost of continuing health care coverage under the applicable Benefit
Plans for her and her dependents during the Severance Period;

 

		(f)	as of the Date of Termination, fully vest all outstanding equity grants including any outstanding
stock options.

    	12

    	

    

		7.06	Fair and Reasonable

 

The Employee acknowledges
and agrees that:

 

(1) the notice or
payments or benefits or any combination thereof provided pursuant to this Article 7 will be in full satisfaction of all rights
and obligations resulting from the termination of the Employee’s employment, including any notice of termination, indemnity
or pay in lieu thereof and severance pay to which the Employee may be entitled pursuant to the applicable legislation;

 

(2) except as provided
in this Article 7, the Employee will not be entitled to any further termination payments, damages, or compensation whatsoever;
and

 

(3) as a condition
precedent to any payment or benefit pursuant to Section 7.03(c), the Employee agrees to deliver to the Corporation prior to receipt
of any such payment or benefit, a full and final release of all actions or claims in connection with the Employee’s employment
or termination of such employment in favour of the Corporation, its Affiliates, Subsidiaries, directors, officers, employees and
agents, in a form satisfactory to the Corporation.

 

	7.07	Return of Property

 

Upon any termination
of his employment with the Corporation, or at any other time at the request of the Corporation, the Employee will deliver or cause
to be delivered to the Corporation promptly all books, documents, money, securities or other property of the Corporation that are
in the possession, charge, control or custody of the Employee.

 

	7.08	Resignation as Director and Officer

 

Upon any termination
of the Employee’s employment under this Agreement, the Employee will be deemed to have resigned, and will, if requested,
sign forms of resignation indicating his resignation, as an officer and director of the Corporation and, if applicable, of any
of its Affiliates. The Employee’s execution of this Agreement shall be deemed the grant by the Employee to the officers of
the Corporation of a limited irrevocable power of attorney (which is deemed coupled with an interest) to sign in the Employee’s
name and on the Employee’s behalf any such documentation as may be required to be executed solely for the limited purposes
of effectuating such resignations.

 

	7.09	Provisions which Operate Following Termination

 

Notwithstanding any
termination of the Employee’s employment under this Agreement, the provisions of Section 4.05 and Articles 5 and 6 of this
Agreement and any other provisions of this Agreement necessary to give efficacy thereto will continue in full force and effect
following such termination.

    	13

    	

    

Article
8 - GENERAL

 

	8.01	Notices

 

Any demand, notice or
other communication (“Communication”) to be given in connection with this Agreement will be given in writing
by personal delivery, by registered mail or by electronic means of communication addressed to the recipient as follows:

 

To the Corporation:

 

Clementia Pharmaceuticals Inc.

4150 Sainte-Catherine Street West, Suite 550

Montreal, Quebec, H3Z 2Y5

 

Attention: Dr. Clarissa Desjardins

Fax: 1-888-966-0135

 

To the Employee:

 

 

or such other address,
individual or electronic communication number as may be designated by notice given by either party to the other. Any Communication
given by personal delivery will be conclusively deemed to have been given on the day of actual delivery of the Communication and,
if given by registered mail, on the third day following the deposit of the Communication in the mail (provided that if such third
day is not a Business Day, then it will be deemed to have been given on the next succeeding day that is a Business Day), and, if
given by electronic communication, on the day of transmittal of the Communication if given during the normal business hours of
the recipient and on the Business Day during which such normal business hours next occur if not given during such hours on any
day. If the party giving any Communication knows or ought reasonably to know of any difficulties with the postal system which might
affect the delivery of mail, any such Communication may not be mailed but must be given by personal delivery or by electronic communication.

 

	8.02	Time of Essence

 

Time will be of the
essence of this Agreement.

 

	8.03	Deductions

 

The Corporation will
deduct all statutory deductions from any amounts to be paid to the Employee under this Agreement.

 

		8.04	Assignment

 

This Agreement and the
Employee’s rights and obligations hereunder may not be assigned by the Employee. The Corporation may assign its rights together
with its obligations hereunder in connection with any sale, transfer or other disposition of all or substantially all of

    	14

    	

    

its business and assets;
and such rights and obligations shall inure to and be binding upon any successor to all or substantially all of the business and
assets of the Corporation, whether by merger, purchase of shares or assets, reorganization or otherwise.

 

	8.05	Entire Agreement

 

This Agreement constitutes
the entire agreement between the parties with respect to the Employee’s employment with the Corporation and cancels and supersedes
any prior understandings and agreements between the parties with respect to the Employee’s employment with the Corporation,
including the Employment Agreement. There are no representations, warranties, forms, conditions, undertakings or collateral agreements,
express, implied or statutory between the parties with respect to the Employee’s employment with the Corporation other than
as expressly set forth in this Agreement.

 

	8.06	Pre-Contractual Representations

 

The Employee hereby
waives any right to assert a claim based on any pre- contractual representations, negligent or otherwise, made by the Corporation.

 

	8.07	Amendments and Waivers

 

No amendment to this
Agreement will be valid or binding unless set forth in writing and duly executed by both of the parties to this Agreement. No waiver
of any breach of any provision of this Agreement will be effective or binding unless made in writing and signed by the party purporting
to give the same and, unless otherwise provided in the written waiver, will be limited to the specific breach waived.

 

	8.08	Severability

 

If any provision of
this Agreement is determined to be invalid or unenforceable in whole or in part, such invalidity or unenforceability will attach
only to such provision or part of such provision and the remaining part of such provision and all other provisions of this Agreement
will continue in full force and effect.

 

	8.09	Governing Law

 

This Agreement will
be governed by and construed in accordance with the laws of the Province of Quebec and the laws of Canada applicable in Quebec,
without regard to conflict of laws provisions.

 

	8.10	Jurisdiction

 

For the purpose of all
legal proceedings this Agreement will be deemed to have been performed in the Province of Quebec and the courts of the Province
of Quebec will have jurisdiction to entertain any action arising under this Agreement. The Corporation and the Employee each hereby
agrees to the jurisdiction of the courts of the Province of Quebec.

    	15

    	

    

	8.11	Copy of Agreement

 

The Employee hereby
acknowledges receipt of a copy of this Agreement duly signed by the Corporation.

 

	8.12	Language

 

The parties hereto acknowledge
that they have requested and are satisfied that this Agreement and all related documents be drawn up in the English language. Les
parties aux présentes reconnaissent avoir requis que la présente entente et les documents qui y sont relatifs soient
rédigés en anglais.

 

[Signature page follows]

    	16

    	

    

IN WITNESS WHEREOF the parties have executed
this Agreement.

 

	 	 	CLEMENTIA PHARMACEUTICALS INC.
	 	 	 	 	 
	 	 	By:	 	 
	 	 	Name:	Dr. Clarissa Desjardins	 
	 	 	Title:	President and CEO	 
	 	 	 	 	 
	WITNESS:	 	 	 
	 	 	 	 
	 	 	 	 
	Signature	 	MR. MICHAEL SINGER	 
	 	 	 	 
	 	 	 	 
	Name (Please print)	 	 	 

    	 

    	

    

SCHEDULE
A

 

JOB DESCRIPTION

 

Chief Financial Officer

 

Basic Function: The chief financial
officer position is accountable for the administrative, financial, and risk management operations of Clementia, to include the
development of a financial and operational strategy, metrics tied to that strategy, and the ongoing development and monitoring
of control systems designed to preserve company assets and report accurate financial results. Principal accountabilities are:

 

	1.	Planning

 

		1.	Assist in formulating the company’s future direction and supporting tactical initiatives

 

		2.	Monitor and direct the implementation of strategic business plans

 

		3.	Develop financial and tax strategies

 

		4.	Manage the capital request and budgeting processes

 

		5.	Develop performance measures that support the company’s strategic direction

 

	2.	Operations

 

		1.	Participate in key decisions as a member of the executive management team

 

		2.	Maintain in-depth relations with all members of the management team

 

		3.	Manage the accounting, human resources, investor relations, legal, tax, and treasury departments

 

		4.	Oversee the financial operations of subsidiary companies and foreign operations

 

		5.	Manage any third parties to which functions have been outsourced

 

		6.	Oversee the company’s transaction processing systems

 

		7.	Implement operational best practices

 

		8.	Oversee employee benefit plans, with particular emphasis on maximizing a cost-effective benefits package

 

		9.	Supervise acquisition due diligence and negotiate acquisitions

    	A-1

    	

    

	3.	Financial Information

 

		1.	Oversee the issuance of financial information

 

		2.	Personally review and approve all filings with the Securities and Exchange Commission

 

		3.	Report financial results to the board of directors

 

	4.	Risk Management

 

		1.	Understand and mitigate key elements of the company’s risk profile

 

		2.	Monitor all open legal issues involving the company, and legal issues affecting the industry

 

		3.	Construct and monitor reliable control systems

 

		4.	Maintain appropriate insurance coverage

 

		5.	Ensure that the company complies with all legal and regulatory requirements

 

		6.	Ensure that record keeping meets the requirements of auditors and government agencies

 

		7.	Report risk issues to the audit committee of the board of directors

 

		8.	Maintain relations with external auditors and investigate their findings and recommendations

 

	5.	Funding

 

		1.	Monitor cash balances and cash forecasts

 

		2.	Arrange for debt and equity financing

 

		3.	Invest funds

 

	6.	Third Parties

 

		1.	Participate in conference calls with the investment community

 

		2.	Maintain banking relationships

 

		3.	Represent the company with investment bankers and investors

    	A-2

    	

    

SCHEDULE B

 

PERMITTED
OUTSIDE DUTIES

 

		·	Board member of Aurora Cannabis Inc. (approx. 4 - 5 meetings per year, 10 - 15 hrs)

    	B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]